| Management of glioblastoma: State of the art and future directions AC Tan, DM Ashley, GY López, M Malinzak, HS Friedman, M Khasraw CA: a cancer journal for clinicians 70 (4), 299-312, 2020 | 1691 | 2020 |
| Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation P Koivunen, S Lee, CG Duncan, G Lopez, G Lu, S Ramkissoon, ... Nature 483 (7390), 484-488, 2012 | 863 | 2012 |
| Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas Y Jiao, PJ Killela, ZJ Reitman, BA Rasheed, CM Heaphy, RF De Wilde, ... Oncotarget 3 (7), 709, 2012 | 708 | 2012 |
| Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas G Jin, ZJ Reitman, CG Duncan, I Spasojevic, DM Gooden, BA Rasheed, ... Cancer research 73 (2), 496-501, 2013 | 161 | 2013 |
| EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis H Feng, GY Lopez, CK Kim, A Alvarez, CG Duncan, R Nishikawa, ... The Journal of clinical investigation 124 (9), 3741-3756, 2014 | 160 | 2014 |
| Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target C Guo, CJ Pirozzi, GY Lopez, H Yan Current opinion in neurology 24 (6), 648-652, 2011 | 110 | 2011 |
| The genetic landscape of gliomas arising after therapeutic radiation GY López, J Van Ziffle, C Onodera, JP Grenert, I Yeh, BC Bastian, ... Acta neuropathologica 137 (1), 139-150, 2019 | 89 | 2019 |
| IDH1R132 mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain GY Lopez, ZJ Reitman, D Solomon, T Waldman, DD Bigner, ... Biochemical and biophysical research communications 398 (3), 585-587, 2010 | 85 | 2010 |
| Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma G López, NAO Bush, MS Berger, A Perry, DA Solomon Acta neuropathologica communications 5 (1), 38, 2017 | 57 | 2017 |
| Late onset N‐acetylglutamate synthase deficiency caused by hypomorphic alleles L Caldovic, H Morizono, MG Panglao, GY Lopez, D Shi, ML Summar, ... Human mutation 25 (3), 293-298, 2005 | 51 | 2005 |
| Biochemical properties of recombinant human and mouse N-acetylglutamate synthase L Caldovic, GY Lopez, N Haskins, M Panglao, D Shi, H Morizono, ... Molecular Genetics and Metabolism 87 (3), 226-232, 2006 | 42 | 2006 |
| Mutant IDH1 is required for IDH1 mutated tumor cell growth G Jin, CJ Pirozzi, LH Chen, GY Lopez, CG Duncan, J Feng, I Spasojevic, ... Oncotarget 3 (8), 774, 2012 | 41 | 2012 |
| Gastrin‐Releasing Peptide, Immune Responses, and Lung Disease S Degan, GY Lopez, K Kevill, ME Sunday Annals of the New York Academy of Sciences 1144 (1), 136-147, 2008 | 41 | 2008 |
| POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families E Shen, J Xiu, GY Lopez, R Bentley, A Jalali, AB Heimberger, ... Journal of medical genetics 57 (10), 664-670, 2020 | 40 | 2020 |
| Transcriptional regulation of N-acetylglutamate synthase SK Heibel, GY Lopez, M Panglao, S Sodha, L Mariño-Ramírez, ... PloS one 7 (2), e29527, 2012 | 35 | 2012 |
| Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1 PJ Cimino, C Ketchum, R Turakulov, O Singh, Z Abdullaev, C Giannini, ... Acta neuropathologica 145 (1), 71-82, 2023 | 34 | 2023 |
| Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3. 3 K27M mutant protein expression GY Lopez, NA Oberheim Bush, JJ Phillips, JP Bouffard, YA Moshel, ... Acta neuropathologica 134 (6), 961-963, 2017 | 25 | 2017 |
| Autoimmune pancerebellitis associated with pembrolizumab therapy JR Vitt, C Kreple, N Mahmood, E Dickerson, GY Lopez, MB Richie Neurology 91 (2), 91-93, 2018 | 23 | 2018 |
| CDKN2A/B loss is associated with anaplastic transformation in a case of NTRK2 fusion-positive pilocytic astrocytoma GY López, A Perry, B Harding, M Li, M Santi Neuropathology and applied neurobiology 45 (2), 174, 2018 | 22 | 2018 |
| Frequent mutations of POT1 distinguish pulmonary sarcomatoid carcinoma from other lung cancer histologies E Shen, J Xiu, R Bentley, GY López, KM Walsh Clinical Lung Cancer 21 (6), e523-e527, 2020 | 10 | 2020 |
David M. AshleyDuke UniversityVerified email at duke.edu